Clinical Trial Update: Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis [NA]

View source ↗

Summary

The clinical trial evaluating anticoagulation for non-occlusive portal vein thrombosis in patients with liver cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Vein Thrombosis

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Liver Cirrhosis, Portal Vein Thrombosis | NA | Status: WITHDRAWN